Lonza Receives Swissmedic Approval for Highly Potent Biologics Drug Product Filling Line in Stein (CH)

Curiosis Inc.Working capital per share of Curiosis, Inc. – KRX:494120 - TradingView

Lonza NewsLonza Group AG stock (CH0013841017): Is its biopharma contract focus strong enough to unlock new ups - AD HOC NEWS

CellB cell deficiency limits exercise capacity by remodeling liver glutamate metabolism

CellA phytoscreen identifies a garlic compound as a deterrent of mating and egg laying in <em>Drosophila</em> and mosquitoes

Cellp53 safeguards chemical reprogramming of human somatic cells toward pluripotency

Cell2'3'-cGAMP-induced membrane shearing promotes broad antiphage immunity

CellGut microbiome is associated with recurrence-free survival in patients with resected high-risk melanoma receiving adjuvant immune checkpoint blockade

FierceBiotechAACR: Endeavoring to go global, Zai Lab offers reality check on China’s biotech ascent

NVIDIAGoogle developing inference AI chips to rival Nvidia - qz.com

CorningSpring book sale returns to benefit Southeast Steuben County Library - WETM

BioPharma DiveRFK Jr. defends HHS tenure, 12% proposed budget cut

Insilico MedicineInsilico Medicine Highlights AI Benchmarking Platform for Drug Discovery - TipRanks